Clinical Trials Directory

Trials / Unknown

UnknownNCT04411615

Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery

Conditions

Interventions

TypeNameDescription
DRUGOmega 3rTG form Omega-3

Timeline

Start date
2020-07-01
Primary completion
2020-08-01
Completion
2021-02-28
First posted
2020-06-02
Last updated
2020-06-02

Source: ClinicalTrials.gov record NCT04411615. Inclusion in this directory is not an endorsement.

Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery (NCT04411615) · Clinical Trials Directory